Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.810
+0.010 (0.26%)
Aug 26, 2026, 3:58 PM AEST
Vitrafy Life Sciences Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 26.1 | 19.52 | 6.41 | 1.72 | 0.96 |
Short-Term Investments | 15.12 | 10.12 | 0.04 | 0.04 | 0.02 |
Cash & Short-Term Investments | 41.22 | 29.65 | 6.45 | 1.76 | 0.98 |
Cash Growth | 39.05% | 359.48% | 266.56% | 78.74% | - |
Accounts Receivable | 0.11 | 0.06 | 0.03 | 0.03 | - |
Other Receivables | 1.04 | 1.55 | 2.17 | 2.11 | 1.94 |
Receivables | 1.15 | 1.61 | 2.2 | 2.14 | 1.94 |
Prepaid Expenses | - | - | 0.38 | - | - |
Other Current Assets | - | - | - | - | 0.56 |
Total Current Assets | 42.38 | 31.25 | 9.03 | 3.9 | 3.49 |
Property, Plant & Equipment | 0.84 | 0.59 | 0.75 | 1.03 | 0.88 |
Total Assets | 43.21 | 31.84 | 9.78 | 4.93 | 4.37 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 1.27 | 0.56 | 0.27 | 0.44 | 0.24 |
Accrued Expenses | 0.36 | 0.43 | 0.43 | 0.32 | 0.23 |
Short-Term Debt | - | - | 22.86 | 8.55 | 7.5 |
Current Portion of Leases | 0.06 | 0.09 | 0.08 | 0.09 | 0.07 |
Current Unearned Revenue | - | 1.43 | - | - | - |
Other Current Liabilities | 0.09 | 0.21 | 10.31 | 9.55 | 3.23 |
Total Current Liabilities | 1.78 | 2.72 | 33.95 | 18.95 | 11.26 |
Long-Term Leases | 0.24 | 0.3 | 0.39 | 0.54 | 0.34 |
Pension & Post-Retirement Benefits | 0.08 | 0.05 | 0.03 | 0.07 | 0.04 |
Total Liabilities | 2.1 | 3.08 | 34.38 | 19.56 | 11.64 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 117.66 | 89.69 | 5.19 | 4.92 | 4.83 |
Retained Earnings | -76.55 | -60.92 | -29.79 | -20.23 | -12.42 |
Comprehensive Income & Other | - | - | - | 0.68 | 0.32 |
Shareholders' Equity | 41.11 | 28.77 | -24.6 | -14.63 | -7.27 |
Total Liabilities & Equity | 43.21 | 31.84 | 9.78 | 4.93 | 4.37 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.3 | 0.39 | 23.33 | 9.19 | 7.91 |
Net Cash (Debt) | 40.92 | 29.25 | -16.88 | -7.43 | -6.93 |
Net Cash Growth | 39.88% | - | - | - | - |
Net Cash Per Share | 0.64 | 0.65 | -5.50 | -2.52 | -2.37 |
Filing Date Shares Outstanding | 75.39 | 63.85 | 3.12 | 2.98 | 2.93 |
Total Common Shares Outstanding | 75.39 | 63.85 | 3.12 | 2.98 | 2.93 |
Working Capital | 40.59 | 28.53 | -24.92 | -15.05 | -7.77 |
Book Value Per Share | 0.55 | 0.45 | -7.90 | -4.91 | -2.48 |
Tangible Book Value | 41.11 | 28.77 | -24.6 | -14.63 | -7.27 |
Tangible Book Value Per Share | 0.55 | 0.45 | -7.90 | -4.91 | -2.48 |
Machinery | 0.14 | 0.75 | 0.74 | 0.73 | 0.64 |
Construction In Progress | 0.53 | - | - | - | - |